160 related articles for article (PubMed ID: 30765319)
1. Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.
Cornett A; Athwal HK; Hill E; Murphy G; Yeoh K; Moskaluk CA; Witt RL; D'Silva NJ; Agarwal S; Lombaert IMA
EBioMedicine; 2019 Mar; 41():175-184. PubMed ID: 30765319
[TBL] [Abstract][Full Text] [Related]
2. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
[TBL] [Abstract][Full Text] [Related]
3. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
[TBL] [Abstract][Full Text] [Related]
4. MYB-NFIB Translocation by FISH in Adenoid Cystic Carcinoma of the Head and Neck in Nigerian Patients: A Preliminary Report.
Owosho AA; Adesina OM; Odujoko O; Soyele OO; Komolafe A; Bauer R; Holte K; Summersgill KF
Head Neck Pathol; 2021 Jun; 15(2):433-437. PubMed ID: 32857249
[TBL] [Abstract][Full Text] [Related]
5. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
7. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenograft (PDX) tumors increase growth rate with time.
Pearson AT; Finkel KA; Warner KA; Nör F; Tice D; Martins MD; Jackson TL; Nör JE
Oncotarget; 2016 Feb; 7(7):7993-8005. PubMed ID: 26783960
[TBL] [Abstract][Full Text] [Related]
9. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic carcinoma: clinical and molecular features.
Moskaluk CA
Head Neck Pathol; 2013 Mar; 7(1):17-22. PubMed ID: 23463073
[TBL] [Abstract][Full Text] [Related]
11. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract][Full Text] [Related]
12. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
13. MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.
Jiang Y; Gao R; Cao C; Forbes L; Li J; Freeberg S; Fredenburg KM; Justice JM; Silver NL; Wu L; Varma S; West R; Licht JD; Zajac-Kaye M; Kentsis A; Kaye FJ
Oral Oncol; 2019 Nov; 98():147-155. PubMed ID: 31606723
[TBL] [Abstract][Full Text] [Related]
14. A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.
Chen C; Choudhury S; Wangsa D; Lescott CJ; Wilkins DJ; Sripadhan P; Liu X; Wangsa D; Ried T; Moskaluk C; Wick MJ; Glasgow E; Schlegel R; Agarwal S
Sci Rep; 2017 Sep; 7(1):11410. PubMed ID: 28900283
[TBL] [Abstract][Full Text] [Related]
15. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.
Persson M; Andrén Y; Moskaluk CA; Frierson HF; Cooke SL; Futreal PA; Kling T; Nelander S; Nordkvist A; Persson F; Stenman G
Genes Chromosomes Cancer; 2012 Aug; 51(8):805-17. PubMed ID: 22505352
[TBL] [Abstract][Full Text] [Related]
16. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
[TBL] [Abstract][Full Text] [Related]
17. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
[TBL] [Abstract][Full Text] [Related]
18. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.
Persson M; Andrén Y; Mark J; Horlings HM; Persson F; Stenman G
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18740-4. PubMed ID: 19841262
[TBL] [Abstract][Full Text] [Related]
19. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
20. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
